Jorge Arca-Suárez

23PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMedical infection agents (incl. prions)Medical bacteriologyMycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 29, 2026
Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing <i>Escherichia coli</i> and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in <i>Pseudomonas aeruginosa</i>.

|Mar 27, 2026
Emergence of KPC-producing <i>Pseudomonas aeruginosa</i> in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

|Feb 19, 2026
Disarming carbapenemase-producing <i>Acinetobacter baumannii</i>: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310).

Salud Rodríguez-Pallares, Michelle Outeda-García, Emilio Lence

|Dec 22, 2025
Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants.

Gabriela-Alejandra Báez-Barroso, Arianna Rodríguez-Coello, Juan Carlos Vázquez-Ucha

|Oct 21, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in <i>Pseudomonas aeruginosa</i>.

Lucía González-Pinto, María Antonia Gomis-Font, Gloria Pérez-Rodríguez

Pageof 4

Frequent Collaborators

21 joint publications

Alejandro Beceiro

17 joint publications

Germán Bou

12 joint publications

Lucía González-Pinto

11 joint publications

Tania Blanco-Martín